Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Von Willebrand Factor (VWF) is a large multimeric glycoprotein essential for primary hemostasis, acting as a bridge between platelets and the vascular subendothelium at sites of injury (UniProt P04275; NIH MedlinePlus). It also serves as a critical carrier protein for Factor VIII (FVIII), protecting it from premature degradation in the bloodstream (UniProt P04275). The endogenous coagulation cascade consists of a series of serine proteases and cofactors—including Factors XII, XI, IX, VIII, X, V, and Prothrombin—that undergo sequential activation to ultimately generate thrombin and a stable fibrin clot (StatPearls, Physiology, Coagulation Cascade). Dysregulation of these components leads to either pathological bleeding, such as in Von Willebrand}
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Von Willebrand Factor (VWF) and endogenous coagulation cascade components (VWF and coagulation factors).